A Short Information Manual on: The Tanzania National Drug Policy, The Master Plan for the Pharmaceutical Sector 1992-2000 Tanzania Mainland - A Summary, Hospital Therapeutic Committees: A. The Tanzania National Drug Policy: 3. Tanzania National Drug Policy 1991: II. Drug Availability: 3. Distribution

Home page | Help | Clear

English | French

Full TOC

Expand Document

Expand Chapter

Preferences

Printable HTML version

Export document as HTML file Help


A Short Information Manual on: The Tanzania National Drug Policy, The Master Plan for the Pharmaceutical Sector 1992-2000 Tanzania Mainland - A Summary, Hospital Therapeutic Committees (WHO; 1993; 42 pages)
	Foreword
	A. The Tanzania National Drug Policy
		1. Background
		2. Initial Activities
		3. Tanzania National Drug Policy 1991
			I. Introduction*
			II. Drug Availability
				1. Drug selection
				2. Drug procurement
				3. Distribution
				4. Quality assurance
			III. Rational Drug Use
				1. Education and Training
				2. Drug Information
				3. Control of Misuse
				4. Hospital Pharmaceuticals and Supplies Committees
				5. Advertising and Promotion
			IV. National Pharmaceutical Production
				1. Promotion
				2. Product Range and Coordination
				3. Pricing mechanisms
			V. Traditional Medicine
				1. Promotion
				2. Research and Production
				3. Safety and Use
			VI. Intersectoral Cooperation
			VII. Technical Cooperation with Other Countries
			VIII. Financial Resources
			IX. Legislation
		4. Notes of clarification on some statements in the National Drug Policy document
	B. The Masterplan for the Pharmaceutical Sector of Tanzania Mainland 1992 - 2000
		1. Introduction
		2. Central Medical Stores (CMS)
		3. Pharmaceuticals and Supplies Unit (PSU)
		4. Pharmacy Board
			4.1. General
			4.2. Drug Legislation
			4.3. Drug Registration
			4.4. Drug Inspection
			4.5. Drug Information
			4.6. Drug Advertising and Promotion
		5. Drug Quality Assurance and Control
		6. Local Production of Pharmaceutical Products
		7. Traditional Medicine
		8. Local Financing of Drugs
		9. Conclusions
	C. Hospital Therapeutic Committees
		I. Introduction
		II. Establishing Therapeutic Committees
		III. Functions of Hospital Therapeutic Committees
		IV. Discussion of the Functions
		V. Composition of Hospital Therapeutic Committees
		VI. Support of Hospital Therapeutic Committees

3. Distribution

a. The aim of the drug distribution policy is to ensure that essential drugs are always available to those who need them and are distributed in the most cost- effective manner.

b. Only registered drugs will be distributed in the country (see note 3).

c. Drugs will continue to be distributed through the public, parastatal and private sectors.

- The CMS will distribute drugs to the health sector according to the National Essential Drug List of Tanzania (NEDLIT).

- Parastatals, other private organisations and the private pharmacies will distribute essential drugs as a priority.

d. In the pharmacies the sale of essential drugs under generic names at low cost will be promoted.

e. A better coordination among the three sectors will be sought, mainly in the field of transportation and storage.

f. Storage, inventory control, quality surveillance facilities will be modernized to meet the requirements of an effective distribution system.

Please provide your feedback

English | French